This drug had not previously been considered by the PBAC for this indication. Osteoporosis must be confirmed by the finding of low bone mass of at least 2 standard deviations below the gender specific ...

In this analysis, 3 bisphosphonates (alendronate, pamidronate, and zoledronic acid) and 1 RANK ligand inhibitor (denosumab) were evaluated for their effectiveness at preventing osteoclasts from ...

BANGALORE, Sept 12 (Reuters) - India's Sun Pharmaceutical Industries said it has received approval from the U.S. Food and Drug Administration to market alendronate sodium tablets, the generic version ...

Please provide your email address to receive an email when new articles are posted on . Denosumab as a first-line osteoporosis therapy is linked to lower fracture risks than alendronate among ...

Romosozumab plus alendronate vs alendronate alone was associated with improved lumbar spine BMD among postmenopausal women with T2D and osteoporosis. Romosozumab followed by alendronate treatment ...

Credit: Shutterstock. Treatment with Prolia was associated with greater reductions in the overall relative risk across various fracture types. Treatment with denosumab (Prolia ®) was associated with ...